This fundamental action advances the FDA’s comprehensive plan on tobacco and nicotine regulation to develop a nicotine product standard, make addiction to cigarettes harder to create or sustain and prevent millions of tobacco-related deaths in the United States, according to an FDA statement.
“Despite years of aggressive efforts to tackle the leading cause of preventable disease and death in the United States, tobacco use — largely cigarette smoking — still kills more than 480,000 Americans every single year,” Scott Gottlieb, MD, commissioner of the FDA, said in the statement. “Tobacco use also costs nearly $300 billion a year in direct health care and lost productivity. In fact, cigarettes are the only legal consumer product that, when used as intended, will kill half of all long-term users.”
The advanced notice of proposed rulemaking includes an extensive review of how nicotine affects the creation or sustainment of cigarette addiction, according to the statement. The FDA is seeking public comment and input on the appropriate potential maximum nicotine level, how to implement a product standard (at once or gradually) and what unintended consequences may ensue from lowering nicotine levels.
The FDA issued an advanced notice of proposed rulemaking to lower nicotine in combustible cigarettes to minimally or nonaddictive levels.
Photo credit: Shutterstock
An analysis evaluating one possible nicotine product standard included in the notice and also being published in the New England Journal of Medicine suggested that if implemented, approximately 5 million more adults may quit smoking after 1 year and 33 million individuals, mainly youth and young adults, would avoid becoming regular smokers by 2100, according to the statement. Additionally, the current smoking rate of 15% could drop as low as 1.4% and more than 8 million tobacco-related deaths could be avoided through the end of the century, according to the statement.
Gottlieb noted that although a potential nicotine product standard is at the forefront of the FDA’s approach, the FDA is also moving forward with other aspects of its tobacco and nicotine regulation plan, including better protection for children against the marketing of tobacco products, seeking comment on the role of flavors in the initiation, use and cessation of tobacco products, and modernizing the development of medicinal nicotine replacement products.
“We believe this unprecedented approach to nicotine and tobacco regulation not only makes sense, but also offers us the best opportunity for achieving significant, meaningful public health gain,” Gottlieb said. “As we move forward with these efforts, we have an opportunity to more formally solicit feedback, and we’ll continue to foster a public dialogue to re-shape our country’s relationship with nicotine and seek public input on policies that will guide us toward a healthier future.”
“This milestone places us squarely on the road toward achieving one of the biggest public health victories in modern history and saving millions of lives in the process,” he added.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.